Trastuzumab Completed Phase 2 Trials for Recurrent Breast Cancer / Stage IV Breast Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00004888Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast Cancer